A novel approach: Fighting painkiller addiction at home

December 21, 2016 by Marilynn Marchione
University of Vermont Psychologist Stacey Sigmon holds a tamper-proof electronic pill dispenser in her office in Burlington, Vt., Wednesday, Dec. 21, 2016. People hooked on prescription painkillers were able to use the device to take a drug at home to curb cravings and prevent abuse while waiting to get in a treatment program. In results published in the New England Journal of Medicine on Thursday, Dec. 22, 2016, use of the device showed dramatic results in helping people who use the system to remain free of illicit opioids. (AP Photo/Wilson Ring)

People hooked on prescription painkillers were able to use a drug at home to curb cravings and prevent abuse while waiting to get in a treatment program, finds a small study that gives hope for a new way to fight the opioid problem.

The drug used in the study is usually only given under supervision of a doctor or in settings like jails or , but waiting lists are often months long at many clinics.

"Folks are dying, overdosing, contracting HIV and hepatitis on wait lists," said Stacey Sigmon, a psychologist and drug abuse researcher at the University of Vermont.

She sought a way to tide people over, using a tamper-resistant electronic pill dispenser to allow home use.

The drug, buprenorphine, also sold as Suboxone, attaches to the same brain receptors that opioids like OxyContin, heroin and Vicodin do, so it eases withdrawal symptoms and prevents a "high" if those other drugs are used. Buprenorphine itself is an opioid, so it, too, can be abused at high doses, but it is chemically different and has somewhat less potential for that.

"We programmed the device to make each day's dose only available in a three-hour period," she said. Users had to see researchers regularly for pill counts and tests, and got daily phone calls to check on how they were.

Results were dramatic. Of the 25 people given the device, 88 percent tested free of illicit opioids at four weeks. At eight weeks it was 84 percent and at 12 weeks, 68 percent. None of 25 others in the study who got no anti-addiction care tested clean at any point.

"It's a huge effect. It is a remarkable difference in outcomes," said Dr. Nora Volkow, director of the National Institute on Drug Abuse.

A grant from the U.S. government paid for the pilot study; researchers are seeking a larger one now to look at longer home treatment.

Just over half of participants were able to get into a comprehensive addiction treatment program by the end of the pilot trial. Results were reported in a letter in Thursday's New England Journal of Medicine.

In a second letter in the journal, doctors working with the Gloucester, Massachusetts, police department report on a project to curb overdoses—the Angel Program—which offers referral and transportation to treatment programs without arrest.

Gloucester's program averaged more than a case a day in its first year of operation. From June 2015 through last May, 376 people sought help a total of 429 times. About 37 percent of them lived in Gloucester or the surrounding county, 40 percent were from other parts of the state, 17 percent were homeless, and the rest were from other states.

Similar projects have been adopted by 153 other police departments in 28 states, researchers report.

Explore further: Police-led addiction program in Gloucester shows first-year success, study finds

Related Stories

Team reports on study of waitlisted opioid-dependent adults

December 21, 2016

In rural states like Vermont, opioid-dependent adults desperate for treatment often find themselves stuck on a wait list, sometimes for eight months or more, increasing their risk of continuing to use illicit opioids, contract ...

FDA approves first drug-oozing implant to control addiction

May 26, 2016

Federal health officials on Thursday approved an innovative new option for Americans struggling with addiction to heroin and painkillers: a drug-oozing implant that curbs craving and withdrawal symptoms for six months at ...

Recommended for you

Researchers identify source of opioids' side effects

January 17, 2017

A commercially available drug may help drastically reduce two side effects of opioid painkillers—a growing tolerance and a paradoxical increased sensitivity to pain—without affecting the drugs' ability to reduce pain, ...

CVS generic competitor to EpiPen, sold at a 6th the price

January 12, 2017

CVS is now selling a rival, generic version of Mylan's EpiPen at about a sixth of its price, just months after the maker of the life-saving allergy treatment was eviscerated before Congress because of its soaring cost to ...

Many misuse OTC sleep aids: survey

December 29, 2016

(HealthDay)—People struggling with insomnia often turn to non-prescription sleep remedies that may be habit-forming and are only intended for short-term use, according to a new Consumer Reports survey.

The pill won't kill your sexual desire, researchers say

December 15, 2016

Taking the pill doesn't lower your sexual desire, contrary to popular belief, according to research published in the Journal of Sexual Medicine. The authors of the research, from the University of Kentucky and Indiana University ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.